http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58e5eed2d37b2f2b0c84f341fc87611c
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Hainaut |
| name | Pierre Hainaut |
| given-name | Pierre |
| organization-name | International Agency for Research on Cancer, World Health Organization, Lyon, France. 10IARC, Lyon, France; Mechanisms of Carcinogenesis Section, Molecular Carcinogenesis Group, International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon, France International Prevention Research Institute, 95 Cours Lafayette, 69006 Lyon, France International Agency for Research on Cancer Lyon France; International Prevention Research Institute Lyon France International Agency for Research on Cancer, Lyon, France International Prevention Research Institute, Lyon, France. International Agency for Research on Cancer, 150, cours Albert Thomas, 69372, Lyon, France Institute of Advanced Biosciences University of Grenoble‐Alpes Grenoble France Institute for Advanced Biosciences, Inserm U 1209 CNRS UMR 5309; Université Grenoble Alpes; Allée des Alpes La Tronche France Institut for Advanced Biosciences, INSERM 1209, UMR CNRS 5309, Université Grenoble–Alpes, Grenoble, France. International Prevention Research Institute, Lyon F-69006, France. Institute for Advanced Biosciences, Inserm 1209 CNRS 5309 UGA, Grenoble, France International Agency for Research on Cancer, Gambia Hepatitis Intervention Study, Lyon, France Team of Tumor Molecular Pathology and Biomarker, Institute for Advanced Bioscience, University Grenoble Alpes, INSERM U 1209, CNRS UMR 5309, Grenoble, France Authors' Affiliations: 1Office of Biorepositories and Biospecimen Research, National Cancer Institute, Bethesda, Maryland and 2International Agency for Research on Cancer, Lyon, France Institute for Advanced Biosciences Inserm U1209 CNRS UMR5309 University Grenoble‐Alpes Grenoble France International Agency for Research on Cancer, 69008 Lyon, France; International Prevention Research Institute, France International Agency for Research on Cancer, Lyon, France. Hainaut@iarc.fr Authors' Affiliations: 1International Agency for Research on Cancer and 2International Preventive Research Institute, Lyon, France; 3Cancer Research Center, Moscow, Russia; and 4The Tisch Cancer Institute, Mount Sinai School of Medicine, New York, New York University of Strathclyde School of Global Public Health at iPRI, International Prevention Research Institute, Lyon, France; Institut Albert Bonniot, Institut National de la Santé et de la Recherche Médicale U 823, Grenoble, France. Electronic address: pierre.hainaut@i-pri.org. Department of Prevention and Therapy of Chronic Diseases, Team Tumor Molecular Pathology and BiomarkersInstitute for Advanced Biosciences, Inserm U 1209, UMR 5309 Université Grenoble Alpes, Site Santé, Allée des Alpes38700 La Tronche France Frances A. Shepherd, Bizhan Bandarchi, and Ming-Sound Tsao, University Health Network, Princess Margaret Hospital, and the University of Toronto, Toronto; Lesley Seymour, National Cancer Institute of Canada Clinical Trials Group, Queen's University, Kingston, Ontario, Canada; Caroline Domerg, Jean-Pierre Pignon, Thierry Le Chevalier, Abderrahmane Bourredjem, Gwénaël Le Teuff, and Jean-Charles Soria, Institut Gustave-Roussy and University Paris XI, Paris; Pierre Hainaut and Xiaoli Ma, International Agency... 5Molecular Carcinogenesis Unit, IARC, Lyon, France; and 6IARC, Lyon, France International Agency for Research on Cancer, World Health Organization, Lyon, France International Center for Research and Training, Hospital AC Camargo, Rua Pirapitinguí 204, São Paulo SP 01508 - 020, Brazil; International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France Institute for Advanced Biosciences, Institut National de la Santé et de la Recherche Médicale 1209 Centre National de la Recherche Scientifique 5309 Universitè Grenoble Alpes, Grenoble, France Infections & Cancer Biology Group, International Agency for Research on Cancer 150 Cours Albert Thomas 69372 Lyon France International Agency for Research on Cancer, 150 Cours Albert Thomas, Cedex 08, 69372 Lyon, France 4International Prevention Research Institute, Lyon, France. 1IARC, Lyon, France; IARC, Lyon, France. Authors' Affiliations: 1Medical Oncology Branch and 2Laboratory of Human Carcinogenesis, National Cancer Institute, NIH, Bethesda, Maryland; 3Biostatistics and Epidemiology Unit, Institut Gustave Roussy, Villejuif, France; 4International Agency for Research on Cancer, Lyon, France; 5Institut National de la Santé et de la Recherche Médicale, Université Joseph Fourier, Department of Pathology, Grenoble Hospital, Grenoble, France; 6Institute of Pathology, Medical University of Graz, Graz, Austria; and 7Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria 30Institut Albert Bonniot, Inserm 823, Université Grenoble Alpes, Rond Point de la Chantourne, La Tronche, France. 1IARC; Department of Research, International Prevention Research Institute, 69006 Lyon, France Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Université Grenoble Alpes, 38000 Grenoble, France. International Agency for Research on Cancer, France Université Grenoble-Alpes, Saint-Martin-d’Hères, France; Institute for Advanced Biosciences, Research Center Inserm U1209/CNRS 5309/UGA, Grenoble, France Asper, Ltd., 3 Oru Street, 51014 Tartu, Estonia; Institute of Molecular and Cell Biology, University of Tartu/Estonian Biocentre, 23 Riia Street, 51010 Tartu, Estonia; and International Agency for Research on Cancer, 150, Cours Albert Thomas, F-69372 Lyon Cedex 08, France International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon, France International Prevention Research Institute Lyon France Frances A. Shepherd and Ming-Sound Tsao, Princess Margaret Cancer Centre; University of Toronto, Toronto; Lesley Seymour, Queen’s University, Kingston, Ontario, Canada; Benjamin Lacas, Gwénaël Le Teuff, Jean-Pierre Pignon, Thierry Le Chevalier, and Jean-Charles Soria, Institut Gustave-Roussy; Benjamin Lacas, Gwénaël Le Teuff, Jean-Pierre Pignon, Thierry Le Chevalier, and Jean-Charles Soria, University Paris XI, Paris; Pierre Hainaut, International Agency for Research on Cancer, Lyon; Jean-Yves Douillard,... International Agency for Research on Cancer, Lyon, France. International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon Cedex 08, France. 14IARC, Lyon, France; Institut Albert Bonniot Inserm UJF 823, Grenoble, France Biology Department, Institute for Advanced Biosciences, INSERM 1209 CNRS 5309 UGA, Grenoble, France International Agency for Research on Cancer; Lyon France; International Prevention Research Institute; Lyon France Molecular Carcinogenesis Group, International Agency for Research on Cancer, Lyon, France International Agency for Research on Cancer Lyon France Institute for Advanced Biosciences, Joint Research Center Inserm 1209 CNRS UMR 5309 University Grenoble-Alpes, Site Santé, Allée des Alpes, 38700 La Tronche, France. Institute for Advanced Biosciences, Grenoble Alpes University, Grenoble, France Institute for Advanced Biosciences; Inserm U 1209 CNRS UMR 5309 Université Grenoble Alpes; Site Santé; Allée des Alpes La Tronche France 1IARC, Lyon, France; Departments of Institute for Advanced Biosciences, Inserm 1209 UMR CNRS 5309 Université Grenoble-Alpes, Grenoble, France International Agency for Research on Cancer (IARC), Lyon, France. Institute of Advanced Biosciences, University of Grenoble-Alpes, La Tronche, France 48Institute for Advanced Biosciences (IAB), Inserm U1209, CNRS UMR5309, Université Grenoble-Alpes, Site Santé Grenoble, Allée des Alpes, La Tronche, France. Authors' Affiliations: 1Mary Crowley Cancer Research Centers, Dallas, Texas; 2The University of Texas M.D. Anderson Cancer Center; 3Introgen Therapeutics, Houston, Texas; 4St. Luke's Cancer Center, Bethlehem, Pennsylvania; 5WJB Dorn Veterans Affairs Medical Center, Columbia, South Carolina; 6Emory University School of Medicine, Atlanta, Georgia; 7University of Louisville, Louisville, Kentucky; 8Wayne State University, Detroit, Michigan; 9Hospital General Universitario Vall d' Hebron, Barcelona, Spain; 10Vanderbilt-Ingram Cancer Center, Nashville, Tennessee; 11University of Illinois, Chicago, Illinois; 12IARC, Lyon, France; and 13University of Miami Sylvester Cancer Center, Miami, Florida Authors' Affiliations: 1International Agency for Research on Cancer, Lyon France; 2Aviano Cancer Center, Aviano, Italy; 3Institut National de la Santé et de la Recherche Médicale (INSERM), Lyon, France; 4Imperial College London, London, United Kingdom; 5Centre of Chronic Immunodeficiency, Freiburg Medical Centre and University of Freiburg, Freiburg, Germany; 6Cancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom; 7Julius Center for Health Sciences and Primary Care, Department of Epidemiology, University of Utrecht, Utrecht, the Netherlands; 8 Department of Epidemiology, School of Public Health, Aarhus University, Aarhus, Denmark; 9Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; 10German Institute of Human Nutrition, Potsdam-Rehbrücke, Nuthetal, Germany; 11German Cancer Research Center (DKFZ), Heidelberg, Germany; 12WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical Sc 7IARC, WHO, Lyon, France; and Inserm, CNRS, Univ. Grenoble Alpes, Institute for Advanced Biosciences (IAB), U1209, Team of Tumor Molecular Pathology and Biomarkers, Grenoble, France Unité 823, Ontogenèse et Oncogenèse Moléculaire, Institut Albert Bonniot, INSERM, Université Joseph Fourier, 38706 Grenoble, France; and; Strathclyde Institute of Global Public Health, International Prevention Research Institute, 69006 Lyon, France Institute for Advanced Biosciences UGA‐INSERM U1209‐CNRS UMR5309 Allée des Alpes France International Prevention Research Institute, 69006 Lyon, France;; Institut Albert Bonniot-Institut National de la Santé et de la Recherche Médicale 823, University Grenoble-Alpes, 38706 Grenoble, France; Unit of Mechanisms of Carcinogenesis, International Agency for Research on Cancer, 69372 Lyon Cedex 08, France Section of Molecular Carcinogenesis, International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon Cedex 08, France International Agency for Research on Cancer, Lyon, France; Department of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada; Department of Pathology, Centre Hospitalier Universitaire, Grenoble, France; International Prevention Research Institute, Lyon, France. Electronic address: pierre.hainaut@univ-grenoble-alpes.fr. |
Incoming Links
Total number of triples: 355.